Biotech

All Articles

AC Immune sees 'spots' prospective in Alzheimer's medication records

.After much more than two decades of focus on neurodegenerative health conditions, Swiss biotech a/c...

GSK falls ph. 2 HPV vaccination over lack of best-in-class possible

.GSK has ditched a stage 2 human papillomavirus (HPV) injection from its pipeline after choosing the...

OS Therapies refiles $6M IPO to money HER2 medicine, preclinical ADCs

.Operating system Therapies will list on the NYSE American supply swap this morning via a $6.4 milli...

ALX's waning CD47 action cost sends sell spiraling down

.ALX Oncology's stage 2 stomach cancer cells feedback rate has actually deteriorated. After seeing i...

Ionis centers eye disease from intendeds of Roche-partnered prospect after data dissatisfy

.Yet Another of Ionis Pharmaceuticals' vital midphase readouts has disappointed desires, causing the...

Biogen's CEO mentioned no unsafe deals in 2023. He's ready to be bold

.While Biogen's pharma peers are actually seeking for late-stage properties with little bit of threa...

Instil refills pipeline in $2B biobucks cope with ImmunOnco

.Instil Biography has actually been actually a biotech looking for a pipe after it junked its own le...

Biogen walks away from Denali Alzheimer's collab

.Biogen has restored rights to a very early Alzheimer's health condition program to Denali Therapies...

Takeda faucets new mind of US oncology organization-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of notable management hirings, shootings as w...

Vertex, beaten by AATD again, falls 2 resources on throw out stack

.Vertex's effort to treat a rare genetic health condition has actually attacked yet another obstacle...